PepGen Inc. Files 8-K with Regulatory Updates
Ticker: PEPG · Form: 8-K · Filed: May 28, 2025 · CIK: 1835597
| Field | Detail |
|---|---|
| Company | Pepgen Inc. (PEPG) |
| Form Type | 8-K |
| Filed Date | May 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, regulatory-filing, disclosure
TL;DR
PepGen filed an 8-K on 5/28/25 covering Reg FD, other events, and financials.
AI Summary
PepGen Inc. filed an 8-K on May 28, 2025, reporting on various events. The filing includes information related to Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits. The company's principal executive offices are located at 321 Harrison Avenue, 8th Floor, Boston, Massachusetts.
Why It Matters
This 8-K filing provides important updates and disclosures from PepGen Inc. to the SEC, which are crucial for investors to understand the company's current status and any material events.
Risk Assessment
Risk Level: low — This filing is a routine 8-K report and does not appear to contain any immediately alarming or high-risk information.
Key Players & Entities
- PepGen Inc. (company) — Registrant
- 0000950170-25-078428 (other) — Accession Number
- May 28, 2025 (date) — Date of Report
- 321 Harrison Avenue 8th Floor, Boston, Massachusetts 02118 (address) — Principal Executive Offices
FAQ
What is the primary purpose of this Form 8-K filing for PepGen Inc.?
The Form 8-K filing serves to report current information about specified events, including Regulation FD Disclosures, Other Events, and Financial Statements and Exhibits, as of May 28, 2025.
What is PepGen Inc.'s principal executive office address?
PepGen Inc.'s principal executive offices are located at 321 Harrison Avenue, 8th Floor, Boston, Massachusetts 02118.
When was this Form 8-K filed?
This Form 8-K was filed on May 28, 2025.
What is PepGen Inc.'s state of incorporation?
PepGen Inc. is incorporated in Delaware.
What is the SIC code for PepGen Inc.?
The Standard Industrial Classification (SIC) code for PepGen Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 28, 2025 regarding PepGen Inc. (PEPG).